Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Device Tax Seeming Inevitable, Groups Align On Small-Firm Protections

This article was originally published in The Gray Sheet

Executive Summary

Groups representing the device industry have aligned to push an amendment to the Senate health care reform bill to exempt more pre- and low-profit companies from the proposed $20 billion device tax

You may also be interested in...



House Device Tax Repeal Effort May Raise Profile Of Issue In Election Season

Legislation to repeal the impending medical device excise tax will be sent to a vote on the House floor, raising the profile of the tax as a congressional election issue even as major impediments to repeal remain in the Senate. Meanwhile, the Supreme Court health care reform ruling looms.

Modified Device Tax Remains In Industry's Sights In Post-Election Setting

The results of the 2010 congressional election give some in industry hope that the device excise tax written into the health care reform law can be at least modified in the next Congress before it takes effect.

Modified Device Tax Remains In Industry's Sights In Post-Election Setting

The results of the 2010 congressional election give some in industry hope that the device excise tax written into the health care reform law can be at least modified in the next Congress before it takes effect.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel